Tag:
pharmacies
Latest Headlines
Latest Headlines
Aussie pharmacists decry patient-info pact with Pfizer
Australian pharmacists are angry about a deal giving Pfizer ( $PFE ) access to patients' personal information--for a fee. Under an agreement between the drug giant and the country's Pharmacy Guild,
Compounding exec Cabaliero on shortages, CMOs and biotech
Joe Cabaleiro is executive director at the Pharmacy Compounding Accreditation Board , a nonprofit dedicated to standards and principles for pharmacy compounding. We asked in a phone interview about
Caterpillar aims to curtail drug costs
In a move that outlines the growing influence of employers and insurers on drug-buying, heavy equipment maker Caterpillar has instituted a new health plan that will steer workers toward Wal-Mart and
U.K. regulator to hand baton to new agency
U.K. pharmacies get a new regulator next year as the General Pharmaceutical Council take over from the Royal Pharmaceutical Society of Great Britain. Report
Clamor for flu drugs clears store shelves
Forget runs on shaky banks. Now, the big run is on pharmacies as a nervous public clamors for anti-flu meds. Pharmacies all over the world are running out of Roche's Tamiflu, from Trinidad and Tobago
SPOTLIGHT: States recycle meds to save money
Struggling to keep medical costs in check, states increasingly are recycling prescription medications: Donated either by individuals or institutions, they're redistributed to the uninsured and poor
EU adviser: GSK broke antitrust laws
Here's a big strike against one strategy for protecting drug prices. A European Union advocate general said GlaxoSmithKline violated antitrust laws when it refused to fill Greek wholesalers' orders
NIH launches Avastin-Lucentis trial
Gentlemen (and ladies), start your eye injections. In other Avastin news, the big trial pitting the cancer drug against Genentech sister med Lucentis is now underway. Sponsored by the National
Pfizer's UK distribution spawns backlash
Little did Pfizer know what it was getting into when it signed an
UK assails Pfizer-type distribution
It's not fair. That's what the UK's Office of Fair Trading is saying about Big Pharma's new, streamlined distribution in that country. The OFT says it fears the National Health Service will pay more
